[
  {
    "date": "2023-12-30",
    "symbol": "CRVS",
    "period": "FY",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documenttype": "10-K",
    "documentperiodenddate": "2023-12-31",
    "entityregistrantname": "Corvus Pharmaceuticals, Inc.",
    "entitytaxidentificationnumber": "46-4670809",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityfilenumber": "001-37719",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "863 Mitten Road, Suite 102",
    "entityaddresscityortown": "Burlingame",
    "entityaddresspostalzipcode": 94010,
    "entityaddressstateorprovince": "CA",
    "cityareacode": 650,
    "localphonenumber": "900-4520",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "security12btitle": "Common Stock",
    "securityexchangename": "NASDAQ",
    "tradingsymbol": "CRVS",
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorfirmid": 238,
    "auditorlocation": "San Jose, California",
    "entitycentralindexkey": 1626971,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "cashandcashequivalentsatcarryingvalue": 12620000,
    "availableforsalesecuritiesdebtsecurities": 14529000,
    "accountsreceivablenetcurrent": 26000,
    "prepaidexpenseandotherassetscurrent": 781000,
    "assetscurrent": 27956000,
    "propertyplantandequipmentnet": 236000,
    "operatingleaserightofuseasset": 1149000,
    "equitymethodinvestments": 16123000,
    "otherassetsnoncurrent": 89000,
    "assets": 45553000,
    "accountspayablecurrent": 1525000,
    "operatingleaseliabilitycurrent": 1374000,
    "accruedliabilitiesandotherliabilitiescurrent": 3970000,
    "liabilitiescurrent": 6869000,
    "liabilities": 6869000,
    "commonstockvalue": 5000,
    "additionalpaidincapitalcommonstock": 374363000,
    "accumulatedothercomprehensiveincomelossnetoftax": -967000,
    "retainedearningsaccumulateddeficit": -334717000,
    "stockholdersequity": 38684000,
    "liabilitiesandstockholdersequity": 45553000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 290000000,
    "commonstocksharesissued": 49038582,
    "commonstocksharesoutstanding": 49038582,
    "researchanddevelopmentexpense": 16526000,
    "generalandadministrativeexpense": 6881000,
    "operatingexpenses": 23407000,
    "operatingincomeloss": -23407000,
    "interestincomeandotherexpensenet": 1584000,
    "subleaseincomerelatedparty": 78000,
    "equitysecuritiesfvnirealizedgainloss": -5284000,
    "netincomeloss": -27029000,
    "earningspersharebasic": -0.56,
    "earningspersharediluted": -0.56,
    "weightedaveragenumberofsharesoutstandingbasic": 48025274,
    "weightedaveragenumberofdilutedsharesoutstanding": 48025274,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 66000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -470000,
    "comprehensiveincomenetoftax": -27433000,
    "sharesoutstanding": 49038582,
    "stockissuedduringperiodvalueissuedforservices": 7843000,
    "stockissuedduringperiodsharesissuedforservices": 2461903,
    "stockissuedduringperiodvaluestockoptionsexercised": 12000,
    "stockissuedduringperiodsharesstockoptionsexercised": 23168,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 2147000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentbeforereclassificationadjustmentsnetoftax": 66000,
    "profitloss": -27029000,
    "depreciationdepletionandamortization": 151000,
    "accretionrelatedtomarketablesecurities": -894000,
    "sharebasedcompensation": 2147000,
    "increasedecreaseinaccountsreceivablerelatedparties": -562000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 8000,
    "increasedecreaseinoperatingleaserightofuseasset": 1068000,
    "increasedecreaseinothernoncurrentassets": -40000,
    "increasedecreaseinaccountspayable": -451000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -3578000,
    "increasedecreaseinoperatingleaseliabilities": 1227000,
    "netcashprovidedbyusedinoperatingactivities": -23935000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 47048000,
    "proceedsfrommaturitiesprepaymentsandcallsofavailableforsalesecurities": 62623000,
    "paymentstoacquirepropertyplantandequipment": 34000,
    "netcashprovidedbyusedininvestingactivities": 15541000,
    "proceedsfromissuanceofcommonstocksformarketoffers": 7843000,
    "proceedsfromstockoptionsexercised": 12000,
    "netcashprovidedbyusedinfinancingactivities": 7855000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -539000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 12620000,
    "cashcashequivalentsandshortterminvestments": 27100000,
    "numberoffinancialinstitutions": 2,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P5Y",
    "leaseholdimprovementsusefullife": "Shorter of asset's useful life or remaining term of lease",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 9244150,
    "cashandcashequivalentsfairvaluedisclosure": 12280000,
    "investmentsfairvaluedisclosure": 10356000,
    "assetsfairvaluedisclosure": 22636000,
    "maximumremainingmaturityofmarketablesecurities": "P11M",
    "availableforsaledebtsecuritiesamortizedcostbasis": 10348000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 8000,
    "equitymethodinvestmentownershippercentage": 0.497,
    "incomelossfromequitymethodinvestments": -5284000,
    "assetsnoncurrent": 1427000,
    "liabilitiesnoncurrent": 648000,
    "licenseandcollaborationagreementsupfrontcashpaymentmade": 275000,
    "licenseandcollaborationagreementsminimumannualfee": 25000,
    "licenseandcollaborationagreementsaggregatepotentialmilestonepayments": 2500000,
    "licenseandcollaborationagreementsperiodofwrittennoticefortermination": "P90D",
    "interestreceivable": 37000,
    "prepaidresearchanddevelopmentmanufacturingexpenses": 149000,
    "prepaidfacilityexpenses": 196000,
    "prepaidinsurance": 179000,
    "otherassetscurrent": 220000,
    "propertyplantandequipmentgross": 2678000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 4697000,
    "accrualforpreclinicalandclinicaltrialcurrent": 2302000,
    "accruedmanufacturingexpensecurrent": 675000,
    "employeerelatedliabilitiescurrent": 684000,
    "accruedprofessionalfeescurrent": 64000,
    "otheraccruedliabilitiescurrent": 245000,
    "depreciationandamortization": 200000,
    "commonstockvotingrightsnumberofvotespershare": 1,
    "sharesissued": 2461903,
    "proceedsfromissuanceofcommonstockgross": 7800000,
    "commonstockremainedavailableforsale": 81900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 3617943,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 9244150,
    "numberofsharesreservedforemployeestockpurchaseplan": 400000,
    "commonstockcapitalsharesreservedforfutureissuance": 13262093,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": 1862000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2543500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 282432,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.17,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.43,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.52,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 6.67,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedoutstandingandexercisablenumber": 5368174,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedoutstandingandexercisableweightedaverageexerciseprice": 6.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedoutstandingandexercisableweightedaverageremainingcontractualterm": "P5Y10M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedoutstandingandexercisableaggregateintrinsicvalue": 1995000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpectedtovestoutstandingandexercisablenumber": 3875976,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpectedtovestoutstandingandexercisableweightedaverageexerciseprice": 1.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpectedtovestoutstandingandexercisableweightedaverageremainingcontractualterm": "P9Y29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpectedtovestoutstandingandexercisableaggregateintrinsicvalue": 1451000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsestimatedfairvalueofcommonstock": 1.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 2100000,
    "allocatedsharebasedcompensationexpense": 755000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.039,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.971,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y8M12D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 4500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M7D",
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -27029000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -27029000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.08,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.25,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.03,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.01,
    "effectiveincometaxratereconciliationotheradjustments": -0.01,
    "effectiveincometaxratereconciliationequityinearningslossesofunconsolidatedsubsidiary": -0.05,
    "deferredtaxassetsoperatinglosscarryforwards": 59314000,
    "deferredtaxassetstaxcreditcarryforwards": 10752000,
    "deferredtaxassetspropertyplantandequipment": 138000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 116000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 5883000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsdeferredrent": 384000,
    "deferredtaxassetsinprocessresearchanddevelopment": 6713000,
    "deferredtaxliabilitiesleasingarrangements": 322000,
    "deferredtaxassetsgross": 83300000,
    "deferredtaxassetsvaluationallowance": 82978000,
    "valuationallowancedeferredtaxassetchangeinamount": 6600000,
    "operatinglosscarryforwards": 228700000,
    "taxcreditcarryforwardamount": 9400000,
    "unrecognizedtaxbenefits": 12800000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 119000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 222000,
    "operatingleasecost": 1224000,
    "variableleasecost": 420000,
    "leasecost": 1644000,
    "operatingleasepayments": 1839000,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y1M6D",
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1434000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1434000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 60000,
    "operatingleaseliability": 1374000,
    "relatedpartytransactionamountsoftransaction": 200000,
    "relatedpartythirdpartycosts": 100000,
    "relatedpartythirdpartycostsprioryears": 500000,
    "relatedpartythirdpartycostscurrentyear": 100000,
    "clinicaltrialexpense": 254000,
    "rule10b51arradoptedflag": "false",
    "nonrule10b51arradoptedflag": "false",
    "rule10b51arrtrmntdflag": "false",
    "nonrule10b51arrtrmntdflag": "false"
  }
]